Positions
- Professor of Surgery
-
Division of Surgical Oncology
ÌÇÐÄÊÓÆµ of Medicine
- Faculty Senator
-
ÌÇÐÄÊÓÆµ of Medicine
- Medical Director
-
Surgery
Surgical Oncology
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
- Member
-
Surgery
Surgical Oncology
Elkins Pancreas Center
Houston, Texas, United States
Addresses
- Dan L Duncan Comprehensive Cancer Center (Clinic)
-
O’Quinn Medical Tower at Baylor St. Luke’s Medical Center’s McNair Campus
1919 Old Spanish Trail
Houston, TX, 77054
United States
Phone: (832) 957-6500
Education
- Clinical Fellowship at University of Pittsburgh Medical Center
- 06/2012 - Pittsburgh, Pennsylvania, United States
- Surgical Oncology Fellowship, Pancreatic Surgery Fellowship
- MD from The University of Texas Health Science Center
- 06/2003 - Houston, Texas, United States
- Fellowship at The University of Texas MD Anderson Cancer Center
- 06/2007 - Houston, Texas, United States
- Surgical Oncology, NIH T32 Research Fellowship
- Residency at The University of Texas Health Science Center
- 06/2010 - Houston, Texas, United States
- General Surgery Residency
- BA from The University of Texas At Austin
- 05/1999 - Austin, Texas, United States
- Biology
- Graduate Certificate at Rice University, Jones Graduate School of Business
- Houston
- ÌÇÐÄÊÓÆµ Management
Certifications
- Board Certified
- American Board of Surgery
- Certificate in Complex Surgical Oncology
- Society of Surgical Oncology
- Medical License
- #M5961
- Texas Medical Board
- Fellow of the American College of Surgeons
- (10/26/2014)
- American College of Surgeons
Honors & Awards
- Norton Rose Fulbright Faculty Excellence Award for Teaching & Evaluation
- ÌÇÐÄÊÓÆµ of Medicine
- Early Career Faculty Award for Excellence in Patient Care
- ÌÇÐÄÊÓÆµ of Medicine
- Barry Stephen Smith Memorial Pancreatic Cancer Research Award
- Dan L Duncan Comprehensive Cancer Center
- Star Faculty Award for Excellence in Patient Care
- ÌÇÐÄÊÓÆµ of Medicine (05/2020)
- Chief Resident Faculty Teaching Award
- 2017, 2019
- ÌÇÐÄÊÓÆµ of Medicine
- Houstonia Magazine, Top Doctors
- 2015, 2016, 2017, 2018, 2019, 2020
- Houstonia Magazine
- Texas Monthly, Texas Rising Stars
- 2017, 2017, 2018
- Texas Monthly Magazine
- Faculty Full Tenure
- 2018
- ÌÇÐÄÊÓÆµ of Medicine
- Alpha Omega Alpha
- 2004
- The University of Texas Health Science Center at Houston
- Texas Monthly, Top Doctor
- 2020
- Texas Monthly Magazine
- Gene Guinn MD Outstanding Teaching Faculty Award
- 2020
- ÌÇÐÄÊÓÆµ of Medicine
- 2020 Top Doctor: General Surgery
- Houstonia Magazine
Professional Interests
- Pancreas cancer surgery
- Pancreaticoduodenectomy (Whipple Procedure)
- Surgical oncology
- Stomach cancer
- Colon cancer
- Sentinel Lymph node biopsy
- Distal Pancreatectomy
- HIPEC
- Pancreatic neuroendocrine tumors
- Pancreatic adenocarcinoma
- Minimally invasive surgery
- Laparoscopic colectomy, gastrectomy and adrenalectomy
- Pancreas Cancer
- Gastric Adenocarcinoma
- Neuroendocrine Tumors
- Gastrointestinal Cancer
- Gastrointestinal Stromal Tumors (GIST)
- Gastrectomy
Professional Statement
George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at ÌÇÐÄÊÓÆµ of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.
A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.
During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.
Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at ÌÇÐÄÊÓÆµ of Medicine.
Currently at the Elkins Pancreas Center we are enrolling patients in neoadjuvant, adjuvant, and metastatic clinical trials for pancreatic cancer. In addition, we do have ongoing surgical clinical trials to determine how to optimize acute surgical outcomes.
A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.
During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.
Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at ÌÇÐÄÊÓÆµ of Medicine.
Currently at the Elkins Pancreas Center we are enrolling patients in neoadjuvant, adjuvant, and metastatic clinical trials for pancreatic cancer. In addition, we do have ongoing surgical clinical trials to determine how to optimize acute surgical outcomes.
Videos
Selected Publications
-
Van Buren G, Yang AD, Dallas NA, Gray MJ, Lim SJ, Xia L, Fan F, Somcio R, Wu Y, Hicklin DJ, Ellis LM. " " J. Clin. Oncol.. 2008 Apr 10; 26 (11) : 1836-42.
Pubmed PMID: . -
Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G, Samuel S, Kim MP, Lim SJ, Ellis LM. " " Cancer Res.. 2009 Mar 1; 69 (5) : 1951-7.
Pubmed PMID: . -
Dallas NA, Fan F, Gray MJ, Van Buren G, Lim SJ, Xia L, Ellis LM. " " Cancer Metastasis Rev.. 2007 Dec ; 26 (41337) : 433-41.
Pubmed PMID: . -
Fan F, Gray MJ, Dallas NA, Yang AD, Van Buren G, Camp ER, Ellis LM. " " Mol. Cancer Ther.. 2008 Sep ; 7 (9) : 3064-70.
Pubmed PMID: .
Projects
- Microbiome in Pancreatic Disease
- ÌÇÐÄÊÓÆµ of Medicine
- Elkins Pancreas Center
- Mitigation Strategies for Post Operative Pancreatic Fistulas (POPF)
- ÌÇÐÄÊÓÆµ of Medicine
Memberships
- Texas Medical Association
- American College of Surgeons
- Fellow
- Association for Academic Surgery
- Harris County Medical Society
- Society for Surgical Oncology
- American Hepato-Pancreato-Biliary Association
- The Pancreas Club
Funding
-
U01: Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CSCPDPC). Altered Microbiome in Pancreatitis, Diabetes and Pancreatic Cancer
#1U01DK108326-01 - (06/01/2015 - 06/01/2020)
- Grant funding from National Institute of Diabetes and Digestive and Kidney Diseases
-
R21 Pilot and Feasibility Clinical Research Studies in Digestive Diseases and Nutrition Building a Pancreas Surgery Consortium via Randomized Controlled Trial of Drain Placement
- (06/01/2015 - 06/01/2017)
- Grant funding from NIH
-
Pancreatic Cancer Immunotherapy Co-clinical Trial using Pre-clinical Mouse Model
- (06/01/2017 - 06/01/2019)
- Grant funding from Roderick D. MacDonald Research Fund at Baylor St. Luke’s Medical Center
-
Curing Pancreatic Cancer with NK Cell Immunotherapy
- (06/01/2018 - 06/01/2019)
- Grant funding from Barry Stephen Smith Memorial Pancreatic Cancer Research Award
-
R33 Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation
- (06/01/2019 - 06/01/2024)
- Grant funding from NCI
Skills
- Pancreatic Surgery
- Surgical Oncology
- Gastric Cancer
- Pancreatic Diseases
Languages
Spanish
to edit your profile